Calcimedica, Inc.
Annual report (10-K)
Latest 10-K/A filed Apr 30, 2026. Sentiment + YoY language diff vs prior year. Read sections →
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Calcimedica, Inc.
| Name | Roles | Filings |
|---|---|---|
| Bjerkholt Eric | Director | 9 |
| Stauderman Kenneth A. | Officer | 9 |
| Dunn Michael J. | Officer | 8 |
| Breuil Robert S | Officer | 7 |
| Guerard Frederic | OfficerDirector | 7 |
Top performers
Insiders ranked by realized 90-day signed return on their open-market trades at Calcimedica, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.
| # | Insider | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|
| 1 | Stauderman Kenneth A. | 3 | 67% | +33.0% | +19.2% | +98.1% | -18.3% |
| 2 | Roberts Eric W | 26 | 77% | +32.7% | +18.2% | +118.9% | -27.6% |
| 3 | Hebbar Sudarshan | 3 | 100% | +17.4% | +13.1% | +28.0% | +11.0% |
| 4 | Wilson Robert N | 5 | 60% | +3.7% | +8.0% | +37.8% | -27.6% |
| 5 | Middleton Fred A | 11 | 0% | -22.0% | -19.4% | -19.4% | -27.6% |
| 6 | Sanderling Venture Partners VI Co Investment Fund LP | 9 | 0% | -21.2% | -19.4% | -19.4% | -27.6% |
| 7 | Sanderling Venture Partners VI LP | 9 | 0% | -21.2% | -19.4% | -19.4% | -27.6% |
| 8 | Sanderling Ventures Management VI | 9 | 0% | -21.2% | -19.4% | -19.4% | -27.6% |
| 9 | Sanderling Ventures Management VII | 9 | 0% | -21.2% | -19.4% | -19.4% | -27.6% |
| 10 | Sanderling Ventures VII (Canada), L.P. | 9 | 0% | -21.2% | -19.4% | -19.4% | -27.6% |
All filings
172 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|